The role of 21-hydroxylase in the pathogenesis of adrenal masses: Review of the literature and focus on our own experience
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
An exaggerated response of 17- hydroxyprogesterone (17-OHP) to exogenous ACTH stimulation has been found in 30 to 70% of patients with incidentally discovered adrenal tumors, supporting the concept that congenital 21- hydroxylase deficiency may be a predisposing factor for adrenocortical tumorigenesis. Decreased expression of 21-hydroxylase gene has been observed in sporadic non-functioning adrenocortical adenomas and adrenocortical carcinomas, in agreement with the reduced steroidogenic activity found in these types of tumors. Screening studies for the presence of mutations in CYP21A2 gene, encoding 21-hydroxylase, in patients with sporadic adrenocortical tumors yielded discordant results. Overall, a higher frequency of germline 21-hydroxylase mutation carriers has been found among patients with adrenal tumors, including incidentalomas, than in the general population. However, the presence of mutations did not correlate with endocrine test results and tumor mass features, suggesting that 21-hydroxylase deficiency does not represent a relevant mechanism in adrenal tumorigenesis. Mechanisms leading to reduced 21-hydroxylase expression and activity are still unknown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adrenal carcinomas are rarely found in persons with CAH (270), and only a single pediatric case has been reported (271).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [270]
In the citing paper
“However, the co-occurrence of a rare tumor and a fairly common genetic syndrome make this association unconvincing at this point (76).”
From Adrenocortical carcinoma (2014) · cites this paper as [76]
Citations
Cites
Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones
Payne, A. H., & Hales, D. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0030 · Cited by 1,766
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Incidentally Discovered Adrenal Masses*
KLOOS, R. T., GROSS, M. D., FRANCIS, I. R., KOROBKIN, M., & SHAPIRO, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 828
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas1
Barzon, L., Scaroni, C., Sonino, N., Fallo, F., Paoletta, A., & Boscaro, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5444 · Cited by 254
Adrenocorticotropin insensitivity syndromes
Clark, A. J. L., & Weber, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0351 · Cited by 234
Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.
Jaresch, S., Kornely, E., Kley, H. K., & Schlaghecke, R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1311000 · Cited by 227
Transcriptional regulation of steroid hydroxylase genes by corticotropin
John, M. E., John, M. C., Boggaram, V, Simpson, E. R., & Waterman, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4715 · Cited by 217
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“Adrenal carcinomas have rarely been reported in adults (151) and in only two pediatric patients with CAH (152, 153).”
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
“However, the co-occurrence of a rare tumor and a fairly common genetic syndrome make this association unconvincing at this point (76).”
BackgroundPW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Guengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 214
Falhammar, H., & Torpy, D. J. (2016) · Endocrine Practice · doi:10.4158/ep151085.ra · Cited by 63
Non-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status?
Falhammar, H. (2014) · Endocrine · doi:10.1007/s12020-013-0162-1 · Cited by 38
Pathophysiology, Evaluation, and Medical Management of Adrenal Disorders
Kutikov, A., Crispen, P. L., & Uzzo, R. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00057-8 · Cited by 34
Russian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Kareva, M., & Чугунов, І. (2014) · Problems of Endocrinology · doi:10.14341/probl201460242-50 · Cited by 25
Doleschall, M., Szabó, J. A., Pázmándi, J., Szilágyi, Á., Koncz, K., Farkas, H., Tóth, M., Igaz, P., Gláz, E., Prohászka, Z., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107244 · Cited by 15
Bilateral Adrenal and Testicular Mass in a Patient with Congenital Adrenal Hyperplasia
Pişkinpaşa, H., Dogansen, S. C., Cabuk, F. K., Guzey, D., Sahbaz, N. A., Akdeniz, Y. S., & Mert, M. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.113 · Cited by 9
“One of the CAH complications is bilateral adrenal hyperplasia caused by longstanding ACTH hypersecretion (3, 4, 21).”
BackgroundInfluentialManejo de la patología suprarrenal en Atención Primaria
Unanua, M. P. P., González, Y. M., Pascual, C. M., & García, A. I. G. (2010) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2009.06.001 · Cited by 7
Cera, G., Corsello, A., Novizio, R., Donna, V. D., Locantore, P., & Paragliola, R. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111779 · Cited by 8
“Moreover, in the case of patients refusing glucocorticoid therapy, ACTH levels remain persistently elevated, with a possible increased risk of developing adrenal masses with a potential transformation risk [30].”
BackgroundGuo, F., Xu, B., Chen, G., Liu, J., & Gao, Q. L. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003956 · Cited by 3
“[47] Although peripheral expression was speculative, recent studies detect low levels in peripheral tissues and tumor cells, [48] implying more complex peripheral steroidogenic capabilities than previously assumed.”
Bilateral adrenal myelolipoma linked to primary hypothyroidism
Rivero, L. G., Tristá, S. E. T., Chiong, L. L., Savariego, E. J., & Pacheco, N. D. (2010) · Revista cubana de endocrinología · Cited by 2
Uncommon Adrenal Tumors in Children and Adolescents
Ribeiro, R. C., Galindo, C. R., Pinto, E. M., Zambetti, G. P., & de Figueiredo, B. C. (2017) · Wiley eBooks · doi:10.1002/9781119196235.ch77 · Cited by 3
Uncommon Adrenal Tumors in Children and Adolescents
Ribeiro, R. C., Galindo, C. R., Pinto, E. M., Zambetti, G. P., & de Figueiredo, B. C. (2012) · Wiley eBooks · doi:10.1002/9781118464557.ch67 · Cited by 1
Adenoma corticosuprarrenal no funcionante
Balseiro, E. S. R., Pérez, B. A. A., Pol, D. D., & Marrero, E. B. (2011) · Redalyc (Universidad Autónoma del Estado de México)
Takahashi, S., Yamamoto, S., Yamamoto, A., Shincho, M., Ka, T., Inokuchi, T., Moriwaki, Y., Tsutsumi, Z., Shima, H., Hirota, S., et al. (2008) · The Endocrinologist · doi:10.1097/ten.0b013e318186f0f4 · Cited by 1
Bilateral adrenal myelolipoma linked to primary hypothyroidism
Rivero, L. G., Tristá, S. E. T., Chiong, L. L., Savariego, E. J., & Pacheco, N. D. (2010) · Revista cubana de endocrinología
Rutura Espontânea de Adrenocarcinoma em Portador de Hiperplasia Adrenal Congênita
Ribeiro, R. G., & Feitosa, A. C. R. (2020) · Revista Científica Hospital Santa Izabel · doi:10.35753/rchsi.v1i1.131
(2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32830c6b8e
Walfish, L., Feldman, L. S., Ajise, O., & Rivera, J. A. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag050
“Barzon et al. reviewed the literature and concluded that 30% to 70% of incidental adrenal tumors have 21-OHase deficiency [15].”
Metadata
- Authors
- Barzon, L., Maffei, P., Sonino, N., Pilon, C., Baldazzi, L., Balsamo, A., Del Maschio, O., Masi, G., Trevisan, M., Pacenti, M., & Fallo, F.
- Affiliations
- University of Padua (IT)
- University of Bologna (IT)
- Corresponding author
- Fallo, F.
- Venue
- Journal of Endocrinological Investigation
- Published
- 2007-07
- Volume
- 30
- Issue
- 7
- Pages
- 615-623
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W2084360091
- Cited by
- 24
- References
- 71
- Citations by year
- 2026: 2 · 2024: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 2
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Istituto Oncologico Veneto
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- 21-hydroxylase, CYP21A2, congenital adrenal hyperplasia, adrenal tumors, adrenal adenoma, adrenocortical carcinoma, adrenal incidentaloma, 17-hydroxyprogesterone, ACTH stimulation test, adrenocortical tumorigenesis, germline mutations, steroidogenesis
- MeSH terms
- Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Glucocorticoids, Humans, Steroid 21-Hydroxylase, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Adrenocortical Carcinoma, 17-alpha-Hydroxyprogesterone, Incidental Findings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.